High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease

Autoimmunity

Volumn 49, Issue 4, 2016, Pages 240-247

  Smigoc Schweiger, Darja ^a   Mendez, Andrijana ^b   Kunilo Jamnik, Sabina ^b   Bratanic, Nina ^a   Bratina, Natasa ^a   Battelino, Tadej ^a,c   Brecelj, Jernej ^a,c   Vidan Jeras, Blanka ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^b BLOOD TRANSFUSION CENTRE OF SLOVENIA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Autoimmune diseases; genetic susceptibility; major histocompatibility complex; order of onset; Slovenian population

Indexed keywords

HLA DQ2 ANTIGEN; HLA DR3 ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ALLELE; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENETIC VARIATION; GENOTYPE; HIGH RISK PATIENT; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; AUTOIMMUNITY; COMPLICATION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; RISK;

ALLELES; AUTOIMMUNITY; CELIAC DISEASE; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; RISK;

EID: 84964453211     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2016.1164144     Document Type: Article

References (60)

1. M.H.Cheng,, and M.S.Anderson. 2013. Insights into type 1 diabetes from the autoimmune polyendocrine syndromes. Curr. Opin. Endocrinol. Diabetes Obes. 20: 271–278
2. D.Larizza,, V.Calcaterra, C.Klersy,. 2012. Common immunogenetic profile in children with multiple autoimmune diseases: the signature of HLA-DQ pleiotropic genes. Autoimmunity 45: 470–475
3. J.A.Todd, 2010. Etiology of type 1 diabetes. Immunity 32: 457–467
4. J.M.Sosenko,, J.S.Skyler, J.P.Palmer,. 2013. The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients. Diabetes Care 36: 2615–2620
5. K.E.Lundin,, and L.M.Sollid. 2014. Advances in coeliac disease. Curr. Opin. Gastroenterol. 30: 154–162
6. K.Larsson,, A.Carlsson, E.Cederwall,. 2008. Annual screening detects celiac disease in children with type 1 diabetes. Pediatr. Diabetes 9: 354–359
7. E.J.Hoffenberg,, T.L.McKenzie, K.J.Barriga,. 2003. A prospective study of the incidence of childhood celiac disease. J. Pediatr. 143: 308–314
8. P.Narula,, L.Porter, J.Langton,. 2009. Gastrointestinal symptoms in children with type 1 diabetes screened for celiac disease. Pediatrics 124: e489–e495
9. A.Pham-Short,, K.C.Donaghue, G.Ambler,. 2012. Coeliac disease in type 1 diabetes from 1990 to 2009: higher incidence in young children after longer diabetes duration. Diabet. Med. 29: e286–289
10. S.Simell,, S.Hoppu, T.Simell,. 2010. Age at development of type 1 diabetes and celiac disease-associated antibodies and clinical disease in genetically susceptible children observed from birth. Diabetes Care 33: 774–779
11. G.Valerio,, L.Maiuri, R.Troncone,. 2002. Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus. Diabetologia 45: 1719–1722
12. F.Cerutti,, F.Chiarelli, R.Lorini,. 2004. Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes. Diabetes Care 27: 1294–1298
13. F.Ludvigsson,, J.Ludvigsson, A.Ekbom, and S.M.Montgomery. 2006. Celiac disease and risk of subsequent type 1 diabetes: a general population cohort study of children and adolescents. Diabetes Care 29: 2483–2488
14. P.Concannon,, S.S.Rich, and G.T.Nepom. 2009. Genetics of type 1A diabetes. N. Engl. J. Med. 360: 1646–1654
15. A.S.Louka,, and L.M.Sollid. 2003. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 61: 105–117
16. Z.Xie,, C.Chang, and Z.Zhou. 2014. Molecular mechanisms in autoimmune type 1 diabetes: a critical review. Clin. Rev. Allergy Immunol. 47: 174–192
17. C.E.Taplin,, and J.M.Barker. 2008. Autoantibodies in type 1 diabetes. Autoimmunity 41: 11–18
18. R.Dieli-Crimi,, M.C.Cénit, and C.Núñez. 2015. The genetics of celiac disease: a comprehensive review of clinical implications. J. Autoimmun. 64: 26–41
19. A.Pugliese, 2014. Advances in the etiology and mechanisms of type 1 diabetes. Discov. Med. 18: 141–150
20. M.F.du Pré,, and L.M.Sollid. 2015. T-cell and B-cell immunity in celiac disease. Best Pract. Res. Clin. Gastroenterol. 29: 413–423
21. C.L.Vanderlugt,, and S.D.Miller. 2002. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2: 85–95
22. H.Erlich,, A.M.Valdes, J.Noble,. 2008. Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 57: 1084–1092
23. R.Hermann,, H.Turpeinen, A.P.Laine,. 2003. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 62: 162–169
24. T.Battelino,, N.Ursic-Bratina, V.Dolzan,. 2003. The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes. Eur. J. Immunogenet. 30: 223–227
25. J.A.Noble,, and H.A.Erlich. 2012. Genetics of type 1 diabetes. Cold Spring Harb. Perspect. Med. 2: a007732
26. A.Petrone,, T.Battelino, C.Krzisnik,. 2002. Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies. Tissue Antigens 60: 244–253
27. J.A.Noble,, and A.M.Valdes. 2011. Genetics of the HLA region in the prediction of type1 diabetes. Curr. Diab. Rep. 11: 533–542
28. R.Ploski,, J.Ek, E.Thorsby, and L.M.Sollid. 1993. On the HLA-DQ (alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 41: 173–177
29. A.S.Louka,, S.Nilsson, M.Olsson,. 2002. HLA in coeliac disease families: a novel test of risk modification by the ‘other’ haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens 60: 147–154
30. L.M.Medrano,, B.Dema, A.López-Larios,. 2012. HLA and celiac disease susceptibility: new genetic factors bring open questions about the HLA influence and gene-dosage effects. PLoS One 7: e48403
31. J.A.Noble,, A.M.Valdes, J.A.Lane,. 2006. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility. Hum. Immunol. 67: 999–1004
32. B.A.Lie,, L.M.Sollid, H.Ascher,. 1999. A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens 54: 162–168
33. N.Bratanic,, D.Smigoc Schweiger, A.Mendez,. 2010. An influence of HLA-A, B, DR, DQ and MICA on the occurrence of celiac disease in patients with type 1 diabetes. Tissue Antigens. 76: 208–215
34. D.Smigoc Schweiger,, A.Mendez, S.Kunilo Jamnik,. 2014. Genetic risk for co-occurrence of type 1 diabetes and celiac disease is modified by HLA-C and killer immunoglobulin-like receptors. Tissue Antigens 84: 471–478
35. N.Bratina,, S.Shalitin, M.Phllip, and T.Battelino. 2015. Type 1 diabetes in the young: organization of two national centers in Israel and Slovenia. Zdrav Var. 54: 139–145
36. S.Husby,, S.Koletzko, I.R.Korponay-Szabó,. 2012. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J. Pediatr. Gastroenterol. Nutr. 54: 136–160
37. B.Vidan-Jeras,, S.Buhler, V.Dubois,. 2014. Resolution of HLA-B*44:02:01G, -DRB1*14:01:01G and -DQB1*03:01:01G reveals a high allelic variability among 12 European populations. Tissue Antigens 84: 459–464
38. M.T.Dorak,, W.Shao, H.K.Machulla,. 2006. Conserved extended haplotypes of the major histocompatibility complex: further characterization. Genes and Immunity 7: 450–467
39. M.E.Riccio,, S.Buhler, J.M.Nunes,. 2013. 16(th) IHIW: analysis of HLA population data, with updated results for 1996 to 2012 workshop data (AHPD project report). Int. J. Immunogenet. 40: 21–30
40. IMGT/HLA Database. Available at: https://www.ebi.ac.uk/ipd/imgt/hla/align.html
41. E.Liu,, H.S.Lee, C.A.Aronsson,. 2014. TEDDY Study Group. Risk of pediatric celiac disease according to HLA haplotype and country. N. Engl. J. Med. 371: 42–49
42. P.Margaritte-Jeannin,, M.C.Babron, M.Bourgey,. 2004. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens. 63: 562–567
43. L.Koskinen,, J.Romanos, K.Kaukinen,. 2009. Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations. Immunogenetics 61: 247–256
44. B.Stankovic,, N.Radlovic, Z.Lekovic,. 2014. HLA genotyping in pediatric celiac disease patients. Bosn. J. Basic Med. Sci. 14: 171–176
45. B.Hernández-Charro,, E.Donat, I.Miner,. 2008. Modifying effect of HLA haplotypes located trans to DQB1*02-DRB1*03 in celiac patients of Southern Europe. Tissue Antigens 71: 213–218
46. F.Bao,, L.Yu, S.Babu,. 1999. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J. Autoimmun. 13: 143–148
47. J.M.Barker,, J.Yu, L.Yu,. 2005. Autoantibody “subspecificity” in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care 28: 850–855
48. A.Doolan,, K.Donaghue, J.Fairchild,. 2005. Use of HLA typing in diagnosing celiac disease in patients with type 1 diabetes. Diabetes Care 28: 806–809
49. Z.Sumnik,, O.Cinek, N.Bratanic,. 2006. Risk of celiac disease in children with type 1 diabetes is modified by positivity for HLA-DQB1*02-DQA1*05 and TNF -308A. Diabetes Care 29: 858–863
50. A.Dezsofi,, B.Szebeni, C.S.Hermann,. 2008. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both. J. Pediatr. Gastroenterol. Nutr. 47: 283–287
51. L.M.Emery,, S.Babu, T.L.Bugawan,. 2005. Newborn HLA-DR, DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates. Pediatr. Diabetes 6: 136–144
52. M.Bodd,, C.Y.Kim, K.E.Lundin, and L.M.Sollid. 2012. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease. Gastroenterology 142: 552–561
53. W.Vader,, D.Stepniak, Y.Kooy,. 2003. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc. Natl Acad. Sci. USA 100: 12390–12395
54. E.Donat,, D.Planelles, A.Capilla-Villanueva,. 2009. Allelic distribution and the effect of haplotype combination for HLA type II loci in the celiac disease population of the Valencian community (Spain). Tissue Antigens 73: 255–261
55. F.Megiorni,, and A.Pizzuti. 2012. HLA-DQA1 and HLA-DQB1 in celiac disease predisposition: practical implications of the HLA molecular typing. J. Biomed. Sci. 19: 88
56. B.P.Koeleman,, B.A.Lie, D.E.Undlien,. 2004. Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun. 5: 381–8
57. K.A.McLaughlin,, C.C.Richardson, S.Williams,. 2015. Relationships between major epitopes of the IA-2 autoantigen in type 1 diabetes: implications for determinant spreading. Clin. Immunol. 160: 226–236
58. H.Miyadera,, and K.Tokunaga. 2015. Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism. J. Hum. Genet. 60: 697–702
59. D.Hadley,, W.Hagopian, E.Liu,. 2015. TEDDY Study Group. HLA-DPB1*04:01 protects genetically susceptible children from celiac disease autoimmunity in the TEDDY Study. Am. J. Gastroenterol. 110: 915–920
60. C.Brorsson,, N.Tue Hansen, R.Bergholdt,. 2010. The type 1 diabetes – HLA susceptibility interactome–identification of HLA genotype-specific disease genes for type 1 diabetes. PLoS One 5: e9576